Report copyright - Jubilant Pharma Ltd - Fixed Income meetings on 1 5 · Selling, general and administrative expenses 66.6 76.1 65.1 31.4 31.6 Research and development expenses 26.8 24.8 25.6 13.2 14.1
Please pass captcha verification before submit form